Trials / Conditions / Ovarian Epithelial Cancer

Ovarian Epithelial Cancer

29 registered clinical trials studyying Ovarian Epithelial Cancer — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in O NCT07341100	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	Phase 2
Recruiting	Agnostic Therapy in Rare Solid Tumors NCT06638931	Instituto do Cancer do Estado de São Paulo	Phase 2
Recruiting	Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer NCT06404671	Alexandria University	N/A
Recruiting	Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Ca NCT05937620	Fundacion Clinic per a la Recerca Biomédica	N/A
Terminated	A Biomarker Screening Protocol for Participants With Solid Tumors NCT05891197	Lyell Immunopharma, Inc.	—
Unknown	AMT-151 in Patients With Selected Advanced Solid Tumours NCT05498597	Multitude Therapeutics Inc.	Phase 1
Terminated	A Study to Investigate LYL797 in Adults With Solid Tumors NCT05274451	Lyell Immunopharma, Inc.	Phase 1
Terminated	A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) NCT05001282	Elucida Oncology	Phase 1 / Phase 2
Recruiting	Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors NCT06785077	European Institute of Oncology	N/A
Unknown	Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer NCT03220932	Hospices Civils de Lyon	Phase 3
Unknown	A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritone NCT04029909	Lee's Pharmaceutical Limited	Phase 1
Unknown	Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. NCT03349463	Bital Savir-Baruch	Phase 4
Completed	Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing NCT04823871	Paul Speiser, Prof.MD,	N/A
Suspended	Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer NCT02742428	Gdynia Oncology Center	N/A
Unknown	Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Can NCT03078400	Splash Pharmaceuticals, Inc.	Phase 1
Unknown	Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France NCT02981901	Centre Leon Berard	—
Unknown	Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer NCT02822157	Universitaire Ziekenhuizen KU Leuven	Phase 2
Unknown	p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Ca NCT02435186	Shenzhen SiBiono GeneTech Co.,Ltd	Phase 2
Completed	RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based NCT02489903	EpicentRx, Inc.	Phase 2
Completed	Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Ca NCT02096783	University of Wisconsin, Madison	N/A
Completed	Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Speci NCT02518256	Medical University of Vienna	N/A
Completed	Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma NCT02039388	Medical University of Vienna	N/A
Completed	Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Ca NCT02107937	SOTIO a.s.	Phase 2
Completed	Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Car NCT02107950	SOTIO a.s.	Phase 2
Completed	Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer NCT01631552	Gilead Sciences	Phase 1 / Phase 2
Completed	Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes. NCT02062697	Medical University of Vienna	N/A
Completed	Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia NCT01484015	Wake Forest University Health Sciences	Phase 1
Unknown	Safety of Active Immunotherapy in Subjects With Ovarian Cancer NCT01456065	Life Research Technologies GmbH	Phase 1
Completed	Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors NCT01806350	New Mexico Cancer Research Alliance	N/A